Mazie Tsang

About Mazie Tsang

Mazie Tsang, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Malignant Hematology and Palliative Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report

Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.

Evaluation of culture conducive to academic success by gender at a comprehensive cancer center

Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Impact of Frontline Treatment Strategy on Quality of Life in the First Decade after a Diagnosis of Marginal Zone Lymphoma

Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional …

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Mazie Tsang Information

University

Position

___

Citations(all)

447

Citations(since 2020)

329

Cited By

227

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Mazie Tsang Skills & Research Interests

Malignant Hematology and Palliative Medicine

Top articles of Mazie Tsang

Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report

Journal of Geriatric Oncology

2024/4/11

Maya Abdallah
Maya Abdallah

H-Index: 4

Mazie Tsang
Mazie Tsang

H-Index: 5

Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.

JCO Oncology Practice

2024/3/13

Mazie Tsang
Mazie Tsang

H-Index: 5

Evaluation of culture conducive to academic success by gender at a comprehensive cancer center

The Oncologist

2024/3/1

Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study

Blood Advances

2024/2/5

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Blood

2023/11/28

Impact of Frontline Treatment Strategy on Quality of Life in the First Decade after a Diagnosis of Marginal Zone Lymphoma

Blood

2023/11/28

Mazie Tsang
Mazie Tsang

H-Index: 5

Christopher Strouse
Christopher Strouse

H-Index: 7

Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional …

Blood

2023/11/28

Mazie Tsang
Mazie Tsang

H-Index: 5

Christopher Strouse
Christopher Strouse

H-Index: 7

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Blood

2023/11/28

Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma …

Blood

2023/11/28

Geriatric assessments in older adults with cancer

JAMA oncology

2023/11/1

Mazie Tsang
Mazie Tsang

H-Index: 5

“Celebrating Resilience”: A review of abstracts on functional resilience at the International Society of Geriatric Oncology 2022 annual meeting

2023/9/1

Mazie Tsang
Mazie Tsang

H-Index: 5

P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS

2023/8/1

Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies

Blood advances

2023/7/7

Mazie Tsang
Mazie Tsang

H-Index: 5

Where the Sidewalk Ends: Parenting as a Trainee during COVID-19

Cancer Investigation

2023/7/3

Mazie Tsang
Mazie Tsang

H-Index: 5

Rahul Banerjee
Rahul Banerjee

H-Index: 4

Professional challenges for United States hematology/oncology trainees during COVID-19

Cancer Investigation

2023/7/3

Rahul Banerjee
Rahul Banerjee

H-Index: 4

Mazie Tsang
Mazie Tsang

H-Index: 5

A study of frontline therapy in adults> 80 years with chronic lymphocytic leukemia (CLL).

2023/6/1

Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 US cancer centers

Hematological Oncology

2021/6

Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms

Acta Haematologica

2013/4/1

EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort

Leukemia & lymphoma

2023/4/16

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Blood

2023/11/28

See List of Professors in Mazie Tsang University(University of California, San Francisco)